Insider Transactions in Q1 2024 at Processa Pharmaceuticals, Inc. (PCSA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2024
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
21,000
+20.92%
|
$42,000
$2.45 P/Share
|
|
Feb 06
2024
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
20,000
+25.51%
|
$40,000
$2.53 P/Share
|
|
Feb 01
2024
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
1,500
+5.18%
|
$3,000
$2.4 P/Share
|
|
Jan 31
2024
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
2,500
+8.78%
|
$5,000
$2.37 P/Share
|
|
Jan 30
2024
|
George K Ng Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+33.33%
|
$20,000
$2.7 P/Share
|
|
Jan 30
2024
|
Justin W Yorke |
BUY
Open market or private purchase
|
Indirect |
8,000
+20.39%
|
$16,000
$2.69 P/Share
|
|
Jan 01
2024
|
David Young Pres. Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-0.64%
|
$1,036
$2.79 P/Share
|
|
Jan 01
2024
|
David Young Pres. Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+2.02%
|
-
|
|
Jan 01
2024
|
Patrick Lin Chief Business - Strategy Off |
SELL
Payment of exercise price or tax liability
|
Direct |
539
-1.85%
|
$1,078
$2.79 P/Share
|
|
Jan 01
2024
|
Patrick Lin Chief Business - Strategy Off |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+5.43%
|
-
|
|
Jan 01
2024
|
James H Stanker Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-7.8%
|
$1,036
$2.79 P/Share
|
|
Jan 01
2024
|
James H Stanker Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+20.15%
|
-
|
|
Jan 01
2024
|
Wendy Guy Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-3.12%
|
$736
$2.79 P/Share
|
|
Jan 01
2024
|
Wendy Guy Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+12.43%
|
-
|
|
Jan 01
2024
|
Sian Bigora Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-1.69%
|
$736
$2.79 P/Share
|
|
Jan 01
2024
|
Sian Bigora Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,675
+7.13%
|
-
|